Public signalCompany raiseAuto-indexed · Unverified
Galecto, Inc. raised $285.0M
Galecto, Inc.· Boston, US· Biotechnology· Filed Nov 21, 2025
Galecto, Inc. reported raising capital. Based in Boston, MASSACHUSETTS, US. First sale reported 2025-11-12. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$285.0M
Confidence90%
Raised
$285.0M
Investors
48
Jurisdiction
DELAWARE
On the record
- Location
- Boston, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $285.0M
- Target amount
- $285.0M
- Filing date
- Nov 21, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 48
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $285.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Amit Munshi
Director
Boston, US
Carl Goldfischer
Director
Boston, US
Christopher Cain
Director
Boston, US
Garrett Winslow
Executive Officer
Boston, US
Hans T. Schambye
Executive Officer
Boston, US
Jayson Dallas
Director
Boston, US
Julianne Bruno
Director
Boston, US
Lori Firmani
Executive Officer
Boston, US
Peter Harwin
Director
Boston, US
Sources & provenance
“Operating company sold 285,000,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Nov 21, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyOver $100MCompany Raise
Are you associated with Galecto, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record